If you would like to stay up to date with our future congress activities and other key dates in the inflammatory bowel disease calendar, check out the events table below.
06–09 May 2023
Digestive Disease Week® 2023 will be hosted in Chicago, Illinois, and will include both a live and virtual programme. This prestigious global meeting for professionals in gastroenterology will provide an unparalleled opportunity to delve into exciting new developments with leaders in gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
19 May 2023
On World IBD Day, healthcare professionals in gastroenterology and inflammatory bowel disease patient associations from around the globe will come together to raise awareness of the burden of inflammatory bowel disease and its impact on a person’s well-being.
19–22 June 2023
The British Society of Gastroenterology Annual Meeting is the must-attend event of the year for those who have an interest or specialise in gastroenterology or hepatology. This annual event features a jam-packed programme that explores all aspects of gastroenterology and hepatology and offers dozens of CPD-accredited sessions, a busy exhibition, a scientific poster programme and multiple networking events and social opportunities.
14–17 October 2023
Representing over 30,000 specialists, United European Gastroenterology (UEG) combines the leading European specialist and national societies focussing on digestive health. The annual UEG Week will continue to provide the latest and greatest scientific advancements in gastroenterology as it returns in 2023. Enjoy the best of both worlds with in-person and virtual formats.
UK-IBD-FIL-202203-00031 | Date of preparation July 2023
Adverse events should be reported.
For Great Britain, reporting forms and information can be found at yellowcard.mhra.gov.uk or via the Yellow Card app (download from the Apple App Store or Google Play Store).
Adverse events should also be reported to Galapagos via email to DrugSafety.UK.Ireland@glpg.com or 0800 072 7878.
Adverse events should be reported.
For Northern Ireland, reporting forms and information can be found at yellowcard.mhra.gov.uk or via the Yellow Card app (download from the Apple App Store or Google Play Store).
Adverse events should also be reported to Galapagos via email to DrugSafety.UK.Ireland@glpg.com or 0800 072 7878.
Adverse events should be reported.
For the Republic of Ireland, reporting forms and information can be found at www.hpra.ie and can be reported to HPRA on +353 1 6764971.
Adverse events should also be reported to Galapagos via email to DrugSafety.UK.Ireland@glpg.com or 00800 7878 1345.
Galapagos and the Galapagos logo are registered trademarks of Galapagos NV.
© 2022 Galapagos NV. All rights reserved.
GB-IBD-FIL-202208-00005 |
Date of preparation: October 2023
Contact Us
Galapagos Biotech Ltd
148 Belmont Rd, Uxbridge UB8 1QS
medicalinfo@glpg.com
Contact Us
Galapagos Biotech Ltd
148 Belmont Rd, Uxbridge UB8 1QS
medicalinfo@glpg.com
© Copyright 2021 Galapagos NV
This link will take you away from the Galapagos website and you will be re-directed to a non-Galapagos website. Galapagos does not accept liability for sites controlled by third-parties.
*By choosing the "Healthcare Professional" option, you affirm your status as a healthcare professional in the UK and Ireland and acknowledge that you will receive promotional information pertaining to prescription-only medicines.